![]() |
市场调查报告书
商品编码
1661061
黏合剂辅料市场报告,按产品类型(纤维素、乳糖、多元醇、聚维酮、淀粉和多醣、共加工可压缩辅料等)、应用(片剂和胶囊、基于溶液)和地区划分,2025 年至 2033 年Binder Excipients Market Report by Product Type (Cellulosics, Lactose, Polyols, Povidones, Starch and Polysaccharides, Co-Processed Compressible Excipients, and Others), Application (Tablets and Capsules, Solution Based), and Region 2025-2033 |
2024IMARC Group全球黏合剂辅料市场规模达到 15.3 亿美元。大众对口服药物的需求不断增加、对以患者为中心的配方的日益关注以及广泛的研发活动是推动市场发展的一些关键因素。
黏合剂辅料是药物製剂中的重要成分之一,尤其是在固体口服剂型中使用时。它们用于将药物活性物质和药片或胶囊中的其他成分结合在一起,从而产生稳定且易于管理的最终产品。它们是亲水性分子,可以与配方中的其他成分(例如纤维素衍生物)产生强大的分子间相互作用。增强粉末混合物的压缩性是黏合剂赋形剂的主要目的之一,它使药片或胶囊尽可能保持恆定的大小和形状,保证一致且可预测的剂量。此外,它们有助于增强粉末混合物的流动特性,使其更容易压缩药片或填充胶囊。它们还有助于控制活性成分的释放,这是黏合剂赋形剂的另一个重要功能,同时它们有助于维持药物的治疗效果,这对于药物具有有限的治疗窗口或仅在身体的某些部位吸收至关重要。有多种类型的黏合剂赋形剂可供选择,包括天然和合成聚合物、糖和淀粉
患者对口服药物的需求不断增加,主要推动了全球市场的发展。这是因为它们具有易于管理、方便和剂量准确等多种优点,从而推动了市场的发展。此外,许多製药公司正在大力投资开发新的药片和胶囊配方,这推动了对黏合剂辅料的需求。除此之外,人们越来越关注以患者为中心的配方,以提高患者对药物治疗方案的依从性和坚持性,这极大地支持了市场。同时,需要专门的黏合剂赋形剂的新型药物传输系统(如缓释片和胶囊)的开发也推动了需求。除此之外,对营养保健食品(具有健康益处的膳食补充剂)的需求不断增长,对市场产生了积极影响。此外,随着品牌药物专利到期的数量不断增加,对仿製药的需求也不断增加,这也促进了市场的发展。此外,共加工辅料等新型辅料的开发正在创造积极的市场前景。推动市场发展的其他因素包括对创新疗法的需求不断增长以及医疗保健领域的持续改进。
The global binder excipients market size reached USD 1.53 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 2.18 Billion by 2033, exhibiting a growth rate (CAGR) of 3.82% during 2025-2033. The increasing demand for oral medications among the masses, the growing focus on patient-centric formulations, and extensive research and development activities represent some of the key factors driving the market.
Binder excipients act as one of the essential components in pharmaceutical formulations, especially when utilized in solid oral dose forms. They are employed to bind the pharmaceutical active substances and other elements of a tablet or capsule, resulting in a stable and manageable final product. They are hydrophilic molecules that can generate potent intermolecular interactions with the other components of the formulation, such as cellulose derivatives. Enhancing the powder mixture's compressibility is one of the primary purposes of binder excipients, which provide tablets or capsules with the constant size and shape possible, guaranteeing a consistent and predictable dose. Additionally, they aid in enhancing the powder mixture's flow characteristics, making it simpler to compress tablets or fill capsules. They also aid in controlling the release of the active ingredient release is another crucial function of binder excipients as well as they help in maintaining the therapeutical effect of the medicinal drugs, which is crucial for medications to have a limited therapeutic window or are absorbed only in certain parts of the body. There are several types of binder excipients available, including natural and synthetic polymers, sugars, and starches
The escalating demand for oral medicines among the patients majorly drives the global market. This is due to their several benefits, such as easy administration, convenience, and accurate dosing, which are driving the market. In addition, numerous pharmaceutical companies are investing heavily in the development of new tablet and capsule formulations, which is propelling the demand for binder excipients. Along with this, the growing focus on patient-centric formulations, which are created to improve patient compliance and adherence to a medication regimen, is significantly supporting the market. In line with this, the development of novel drug delivery systems, such as modified-release tablets and capsules, requiring specialized binder excipients is also providing a thrust to the demand. Apart from this, the growing demand for nutraceuticals, which are dietary supplements that offer health benefits, is influencing the market favorably. In addition, the rising demand for generic drugs on account of the increasing number of patents expiring on branded drugs is contributing to the market. Furthermore, the development of novel excipients, such as co-processed excipients, is creating a positive market outlook. Some of the other factors driving the market include the rising demand for innovative therapies and continual improvements in the healthcare sector.